C. West

发表

Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.

D. Baird, M. Lumsden, V. Sweeting, 1992, Human reproduction.

Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot.

D. Baird, J. Williamson, M. Lumsden, 1987, Fertility and sterility.

GOSERELIN THERAPY BEFORE SURGERY FOR UTERINE FIBROIDS

M. Lumsden, D. Baird, C. West, 1987, The Lancet.

9 Hysterectomy and myomectomy by laparotomy

C. West, 1998 .

Treatment with the gonadotrophin releasing hormone‐agonist goserelin before hysterectomy for uterine fibroids

D. Baird, M. Lumsden, H. Hillier, 1994, British journal of obstetrics and gynaecology.

GnRH analogues in the treatment of fibroids

C. West, 1993 .

TAMOXIFEN PROLONGS LUTEAL PHASE IN PREMENOPAUSAL WOMEN BUT HAS NO EFFECT ON THE SIZE OF UTERINE FIBROIDS

D. Baird, M. Lumsden, C. West, 1989, Clinical endocrinology.

Medical management of fibroids

D. Baird, C. West, 1988, British medical journal.

LHRH analogues in the management of uterine fibroids, premenstrual syndrome and breast malignancies.

C. West, 1988, Bailliere's clinical obstetrics and gynaecology.

Treatment of anovulatory infertility: the problem of multiple pregnancy.

H. Jacobs, A. Patel, Anita Patel, 1996, Human reproduction.

Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome.

H. Hillier, C. West, 1994, Human reproduction.

Intrauterine death during continuous subcutaneous infusion of insulin.

J. Steel, C. West, 1985, British medical journal.

Serum and follicular fluid insulin like growth factors I and II during growth hormone co‐treatment for in‐vitro fertilization and embryo transfer

B. Mason, H. Jacobs, C. West, 1991, Clinical endocrinology.

Co-treatment with growth hormone of sub-optimal responders in IVF-ET.

H. Jacobs, B. Mason, C. West, 1991, Human reproduction.

Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial.

H. Jacobs, R. Homburg, C. West, 1990, Fertility and sterility.

Pregnancy after Vitrectomy for Proliferative Diabetic Retinopathy

J. Steel, C. West, L. B. Young, 1987, Diabetic medicine : a journal of the British Diabetic Association.

Homologous intra-uterine insemination has no advantage over timed natural intercourse when used in combination with ovulation induction for the treatment of unexplained infertility.

F. Wu, K. Zikopoulos, P. Thong, 1993, Human reproduction.

A Medical Audit and Patient Survey of Hysterectomies Performed for Menstrual Disorders

V. Wadehra, J. Law, C. West, 1996, Scottish medical journal.

Recombinant follicle-stimulating hormone (follitropin beta, Puregon*) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins †

B. Tarlatzis, P. Devroey, L. Hamberger, 1998 .

9 Fibroids and menorrhagia

M. Lumsden, C. West, 1989 .

Fibroids and menorrhagia.

M. Lumsden, C. West, 1989, Bailliere's clinical obstetrics and gynaecology.

Pregnancy after treatment with three recombinant gonadotropins

H. Jacobs, G. Conway, C. West, 1997, The Lancet.

Proceedings: The effects of nicotinic and muscarinic agonist drugs on the release of catecholamines from the isolated perfused adrenal glands of the dog.

J. Waite, A. Ungar, J. Critchley, 1975, British journal of pharmacology.

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.

G. Kaltsas, G. Conway, A. Balen, 1995, Human reproduction.

SUPPRESSION OF OVARIAN ACTIVITY BY ZOLADEX DEPOT (ICI 118630), A LONG‐ACTING LUTEINIZING HORMONE RELEASING HORMONE AGONIST ANALOGUE

D. Baird, C. West, 1987, Clinical endocrinology.

High risk pregnancies in hypopituitary women.

G. Conway, C. Davis, M. Davies, 2002, Human reproduction.

Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

D. Braat, A. Balen, H. Jacobs, 1994, Human reproduction.

Combined growth hormone and gonadotropin treatment for ovulation induction in patients with non-responsive ovaries.

H. Jacobs, R. Homburg, C. West, 1991, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Treatment with pulsatile luteinizing hormone-releasing hormone modulates folliculogenesis in response to ovarian stimulation with exogenous gonadotropins in patients with polycystic ovaries.

H. Jacobs, R. Homburg, J. Kilborn, 1990, Fertility and sterility.

A DOUBLE‐BLIND STUDY COMPARING A NEW NON‐ERGOT, LONG‐ACTING DOPAMINE AGONIST, CV 205‐502, WITH BROMOCRIPTINE IN WOMEN WITH HYPERPROLACTINAEMIA

H. Jacobs, R. Homburg, C. West, 1990 .

A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia.

H. Jacobs, R. Homburg, C. West, 1990, Clinical endocrinology.

The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).

D. Baird, T. Bramley, M. Lumsden, 1989, The Journal of endocrinology.

Induction of Ovulation with Gonadotrophins—A Ten Year Review

D. Baird, C. West, 1984, Scottish medical journal.

Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome.

C. West, 1990, European journal of obstetrics, gynecology, and reproductive biology.

Modification of symptoms of the premenstrual syndrome during ovarian suppression with goserelin (Zoladex) depot-potential for research and clinical investigation

D. Baird, M. Lumsden, C. West, 1989 .

A COMPARATIVE STUDY OF SINGLE‐DOSE GROWTH HORMONE THERAPY AS AN ADJUVANT TO GONADOTROPHIN TREATMENT FOR OVULATION INDUCTION

R. Homburg, H. Jacobs, C. West, 1990, Clinical endocrinology.

HORMONAL PROFILES IN LACTATING AND NON‐LACTATING WOMEN IMMEDIATELY AFTER DELIVERY AND THEIR RELATIONSHIP TO BREAST ENGORGEMENT

A. Mcneilly, C. West, 1979, British journal of obstetrics and gynaecology.

Age and infertility.

C. West, 1987, British medical journal.

Endometriosis.

C. West, 1990 .

Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.

D. Baird, M. Lumsden, H. Hillier, 1989 .

The acceptability of a progestagen-only contraceptive during breast-feeding.

C. West, 1983, Contraception.

Factors influencing the duration of breast-feeding

C. West, 1980, Journal of Biosocial Science.

Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability.

W. Hannan, M. Lumsden, S. Gow, 1997, Human reproduction.

Hysterectomy and myomectomy by laparotomy.

C. West, 1998, Bailliere's clinical obstetrics and gynaecology.

Proceedings: The release of catecholamines from perfused canine adrenal glands by corticosteroids.

J. Waite, A. Ungar, J. Critchley, 1976, The Journal of physiology.

The Characteristics of 100 Women Presenting to a Gynecological Clinic with Premenstrual Complaints

C. West, 1989, Acta obstetricia et gynecologica Scandinavica.

A reappraisal of the syndrome of premenstrual tension and the role of hormonal manipulation in its management.

C. West, 1989 .

Estrogenic action of tamoxifen in women treated with luteinizing hormone‐releasing hormone agonists (goserelin). Lack of shrinkage of uterine fibroids

M. Lumsden, H. Hillier, C. West, 1990, Fertility and sterility.

Shrinkage of uterine fibroids during therapy with goserelin (Zoladex**Supported by ICI Pharmaceuticals, Macclesfield, United Kingdom, the manufacturer of Zoladex.): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot

D. Baird, J. Williamson, M. Lumsden, 1987 .

The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypooestrogenic by continuous administration of an LHRH agonist

T. Bramley, M. Lumsden, C. West, 1988, British journal of obstetrics and gynaecology.

DANGERS OF CORTICOTROPHIN IN PHÆOCHROMOCYTOMA

J. Waite, C. West, J. Critchley, 1974 .

Goserelin (Zoladex®) in the treatment of fibroids

M. Lumsden, C. West, D. Baird, 1992, British journal of obstetrics and gynaecology.

LHRH analogues and fibroids--potential for longer-term use.

D. Baird, M. Lumsden, C. West, 1989, Hormone research.